What is RMDA's market capitalization?

Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda has a market capitalization of about EGP 12.81B.

Does RMDA pay dividends?

Yes — Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda has a trailing dividend yield of 0.48% (EGP 0.03 per share).

What is RMDA's P/E ratio?

Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda trades at a trailing price-to-earnings ratio of 37.07.

Where can I track RMDA?

This Starta Markets page shows Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda's live EGX quote, key statistics, financial statements, dividends, technicals and news — or ask the Starta AI analyst about RMDA in Arabic or English.

Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) Share Price — EGX

EGP 6.28-0.32%Technicals: Buy

Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) trades on the Egyptian Exchange (EGX) in the Health Technology sector. Last updated 10 Sept 2026, 21:08 (Cairo time). EGX sector classification: Health Care & Pharmaceuticals.

What is Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda’s share price today? RMDA last traded at EGP 6.28 (-0.32% on the day), for a market value of EGP 12.81 billion, a P/E of 37.07 and a dividend yield of 0.48%. Its 52-week range is EGP 3.07 to 6.94.

RMDA price performance

1W: +3.0%
1M: -3.2%
3M: +20.3%
6M: +40.4%
YTD: +89.7%
1Y: +51.5%
5Y: +260.9%

Total return based on EGX closing prices. Past performance does not indicate future results.

About Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, engages in producing, marketing, selling, and storing pharmaceutical reagents for human and veterinary use.It is also involved in producing, marketing, selling, and storing diagnostic reagents for individuals, laboratories, and hospitals; importing pharmaceutical reagents and raw materials; producing pharmaceutical reagents for human, veterinary, and diagnostic use; and producing food supplements for human use.The company was incorporated in 1986 and is based in 6th of October City, Egypt.

Industry:: Pharmaceutical Preparations
ISIN:: EGS381B1C015
Website:: ramedapharma.com

RMDA key statistics

Last price: EGP 6.28
Previous close: EGP 6.3
Day change: -0.32%
52-week range: EGP 3.07 – 6.94
Volume: 2,965,157
Shares outstanding: 2.03B
Free float: 67.68%
Market cap: EGP 12.81B
P/E (trailing): 37.07
P/B: 4.38
Dividend yield: 0.48%
EPS (TTM): EGP 0.17
Revenue (TTM): EGP 4.39B
Net income (TTM): EGP 330.86M
ROE: 12.75%
Book value / share: EGP 1.43
Beta (1Y): 0.47
50-day MA: EGP 5.72
200-day MA: EGP 4.46
RSI (14): 56.39

Data as of 10 Sept 2026, 21:08 (Cairo time). Source: Egyptian Exchange via TradingView; financial statements via Yahoo Finance. Prices refresh every 15 minutes during EGX trading hours (Sun–Thu).

Compare with other Health Technology stocks

Latest Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda news

Key terms behind the RMDA figures

Market Capitalization: Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio: The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio: The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield: Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) share price today?: Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda last traded at EGP 6.28 on the Egyptian Exchange (as of 10 Sept 2026, 21:08, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is RMDA's market capitalization?: Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda has a market capitalization of about EGP 12.81B.
Does RMDA pay dividends?: Yes — Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda has a trailing dividend yield of 0.48% (EGP 0.03 per share).
What is RMDA's P/E ratio?: Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda trades at a trailing price-to-earnings ratio of 37.07.
What sector is Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda in?: Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda is listed on the Egyptian Exchange (EGX) in the Health Technology sector.
Where can I track RMDA?: This Starta Markets page shows Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda's live EGX quote, key statistics, financial statements, dividends, technicals and news — or ask the Starta AI analyst about RMDA in Arabic or English.